Helix BioPharma (TSX:HBP) Dividends per Share : C$0.00 (TTM As of Jul. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma Dividends per Share?

Helix BioPharma's dividends per share for the three months ended in Jul. 2024 was C$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.00. Its Dividend Payout Ratio for the three months ended in Jul. 2024 was 0.00. As of today, Helix BioPharma's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Helix BioPharma Dividends per Share Historical Data

The historical data trend for Helix BioPharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Dividends per Share Chart

Helix BioPharma Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Dividends per Share

Get a 7-Day Free Trial

Helix BioPharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Helix BioPharma's Dividends per Share

For the Biotechnology subindustry, Helix BioPharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helix BioPharma's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's Dividend Yield % falls into.

Helix BioPharma Dividends per Share Calculation

Dividends paid to per common share.

Helix BioPharma (TSX:HBP) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Helix BioPharma's Dividend Payout Ratio for the quarter that ended in Jul. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jul. 2024 )	/	EPS without NRI (Q: Jul. 2024 )
	=	0	/	-0.107
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Helix BioPharma Dividends per Share Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

HBPCF:USA HBP0:Germany

Address

40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.